{"product_id":"stryker-five-forces-analysis","title":"Stryker Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eA Must-Have Tool for Decision-Makers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eStryker faces strong intra-industry rivalry driven by innovation cycles and consolidation, moderate supplier power due to specialized components, and high buyer expectations for quality and value; substitute threats are limited but emerging tech poses risk.\u003c\/p\u003e\n\u003cp\u003eThis brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Stryker’s competitive dynamics, market pressures, and strategic advantages in detail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Raw Material Dependency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eStryker depends on high‑purity inputs—titanium, cobalt‑chrome, and medical‑grade polymers—sourced from a small pool of certified suppliers, giving vendors pricing leverage; in 2024 titanium scrap prices averaged about $5.50\/lb and cobalt spot rose ~22% year‑on‑year, raising input cost risk. Any global disruption (mining strikes, trade limits) can quickly raise Stryker’s production costs and extend lead times by weeks to months.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrict Regulatory Compliance for Vendors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSuppliers in medical tech face strict FDA and ISO 13485 quality rules, raising vendor-entry costs and keeping supplier churn low; for example, 72% of medtech suppliers report regulatory compliance as the top barrier to new contracts (FDA 2024 industry survey).\u003c\/p\u003e\n\u003cp\u003eStryker cannot rapidly swap vendors because supplier requalification often takes 6–12 months and can cost millions in validation and testing.\u003c\/p\u003e\n\u003cp\u003eThat slows sourcing flexibility and boosts incumbent suppliers’ leverage, so Stryker favors proven, compliant partners even if they command 3–7% higher margins to avoid regulatory risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConcentration of High-Tech Component Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAs Stryker adds robotics and digital features to systems like Mako, it relies on specialized semiconductors and software from a handful of global suppliers, cutting Stryker’s bargaining power; the top 5 semiconductor firms held ~60% of market revenue in 2024.\u003c\/p\u003e\n\u003cp\u003eIn 2023–24 chip shortages lifted component costs 15–30% in medtech segments, and single-supplier risks can delay device deliveries, increasing inventory and working-capital needs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSwitching Costs for Specialized Tooling\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMany Stryker components use custom tooling and proprietary processes developed with long-term suppliers; replacing a supplier often needs capital outlays and 3–9 months of re-tooling and validation, raising operational risk and launch delays.\u003c\/p\u003e\n\u003cp\u003eThese high switching costs—estimated at tens of millions for major orthopedic lines—discourage frequent vendor changes, giving suppliers stronger bargaining power over price and lead times.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCustom tooling -\u0026gt; long lead times (3–9 months)\u003c\/li\u003e\n\u003cli\u003eRe-tooling cost -\u0026gt; tens of millions for major lines\u003c\/li\u003e\n\u003cli\u003eValidation risk -\u0026gt; potential regulatory delays\u003c\/li\u003e\n\u003cli\u003eNet effect -\u0026gt; stronger supplier leverage\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eImpact of Global Logistics and Inflation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eRising energy costs and global logistics bottlenecks pushed supplier input prices up about 6–9% in 2024, letting some suppliers pass through increases despite Stryker’s scale.\u003c\/p\u003e\n\u003cp\u003eSystemic manufacturing inflation—US PPI for medical equipment rose ~7% year-over-year in 2024—limits Stryker’s bargaining leverage on costs.\u003c\/p\u003e\n\u003cp\u003eStryker must offset input inflation by improving operational efficiency and pricing to protect 2024 gross margin (~49%).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSupplier price pass-through ~6–9% (2024)\u003c\/li\u003e\n\u003cli\u003eUS medical equipment PPI +7% YoY (2024)\u003c\/li\u003e\n\u003cli\u003eStryker gross margin ~49% (FY2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier leverage squeezes Stryker: long requalification, high input inflation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers hold strong leverage: few certified sources for titanium, cobalt‑chrome, med‑grade polymers and semiconductors, long requalification (6–12 months) and retooling (3–9 months) costs (tens of millions), 2024 input inflation ~6–9% and US med‑equipment PPI +7% cut Stryker’s bargaining power against a ~49% gross margin (FY2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRequalification\u003c\/td\u003e\n\u003ctd\u003e6–12 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetooling\u003c\/td\u003e\n\u003ctd\u003e3–9 months; tens of $M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInput inflation\u003c\/td\u003e\n\u003ctd\u003e6–9%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS med‑equipment PPI\u003c\/td\u003e\n\u003ctd\u003e+7% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStryker gross margin\u003c\/td\u003e\n\u003ctd\u003e~49% FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eTailored Porter's Five Forces analysis for Stryker, uncovering competitive pressures, supplier and buyer influence on pricing, entry barriers, substitute threats, and strategic implications for sustaining market leadership.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise Porter's Five Forces one-sheet for Stryker—quickly spot supplier, buyer, and competitive pressures to guide surgical device strategy and M\u0026amp;A decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidation of Healthcare Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe US hospital market saw 40% of hospitals in systems by 2023, and integrated delivery networks (IDNs) now account for roughly 60% of acute-care spend, giving large buyers strong leverage over suppliers like Stryker.\u003c\/p\u003e\n\u003cp\u003eThese IDNs use procurement volumes—often millions in annual device spend—to extract deeper discounts and tougher service terms, pressuring Stryker’s margins.\u003c\/p\u003e\n\u003cp\u003eStryker must offer competitive pricing and outcome-linked contracts to win multi-year IDN deals; in 2024 Stryker reported 10% of revenue tied to large system contracts, raising negotiation stakes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInfluence of Group Purchasing Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGroup Purchasing Organizations (GPOs) pool buying power of hospitals and clinics—US GPOs negotiated about 70% of acute care hospital purchases in 2024—so inclusion on a GPO’s approved vendor list strongly affects Stryker’s reach.\u003c\/p\u003e\n\u003cp\u003eStryker must compete for GPO contracts; winning can open access to thousands of facilities and drive high-volume sales, while losing can cut off sizeable revenue streams in key US regions.\u003c\/p\u003e\n\u003cp\u003eFailure to secure GPO placement often shifts procurement to competitors and can reduce Stryker’s market share in targeted product categories by double-digit percentages within 12–24 months.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eShift Toward Value-Based Procurement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHealthcare buyers are shifting to value-based procurement, linking payment to outcomes; by 2024 roughly 35% of US Medicare payments were tied to value-based models, so hospitals demand outcome data for Stryker devices. Customers press Stryker for trials showing robotic systems cut length-of-stay or readmissions; studies must demonstrate cost-per-case reductions (eg, $1,200–$3,500 per joint case) to justify premium pricing. This compresses margin unless efficacy is proven.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrice Transparency and Digital Procurement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eDigital procurement platforms raised price transparency in medtech: 2024 Vizient data shows 60% of US hospitals use e-procurement, enabling easier cost comparisons and tighter vendor scrutiny.\u003c\/p\u003e\n\u003cp\u003eBuyers now use benchmarking to flag price gaps, driving tougher negotiations—Stryker saw hospital contract pressure contribute to a 0.8 percentage-point margin compression in 2024.\u003c\/p\u003e\n\u003cp\u003eStryker must keep innovating product differentiation—unique features, bundled services, or outcomes data—to justify premiums in a market where list prices are widely visible.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e60% US hospitals on e-procurement (Vizient, 2024)\u003c\/li\u003e\n\u003cli\u003e0.8 pp margin hit tied to contract pressure (Stryker, 2024 results)\u003c\/li\u003e\n\u003cli\u003eDifferentiate via outcomes data, services, bundles\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBudgetary Constraints in Public Health\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eGovernment-funded hospitals face tight budgets and push Stryker hard on price; in 2024 OECD health spending averaged 9.2% of GDP, tightening procurement choices in many markets.\u003c\/p\u003e\n\u003cp\u003eWhere single-payer systems prevail—Canada, UK, Sweden—the state acts as sole buyer, giving customers exceptional bargaining power and driving centralized tendering and volume discounts.\u003c\/p\u003e\n\u003cp\u003eStryker adapts via tiered pricing, value-based contracting, and local manufacturing; in 2023 the company reported 7% international organic sales growth, reflecting pricing and market mix moves.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePublic buyers more price-sensitive\u003c\/li\u003e\n\u003cli\u003eSingle-payer = high bargaining power\u003c\/li\u003e\n\u003cli\u003eStryker uses tiered pricing, contracts, local sourcing\u003c\/li\u003e\n\u003cli\u003eOECD health spend 9.2% GDP (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBuyer Power, Value-Based Contracts \u0026amp; E‑procurement Squeeze Stryker Margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLarge US IDNs and GPOs (≈60% acute spend; GPOs cover ~70% purchases) give customers strong leverage, forcing Stryker into deeper discounts, outcome-linked deals, and margin pressure (≈0.8 pp in 2024).\u003c\/p\u003e\n\u003cp\u003eValue-based procurement (≈35% Medicare tied to value in 2024) and e-procurement (60% hospitals) raise transparency, so Stryker must use outcomes data, bundles, and tiered pricing to retain share.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eIDN share of acute spend\u003c\/td\u003e\n\u003ctd\u003e≈60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGPO coverage of purchases\u003c\/td\u003e\n\u003ctd\u003e≈70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eE-procurement adoption (US hospitals, 2024)\u003c\/td\u003e\n\u003ctd\u003e60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare value-based payments (2024)\u003c\/td\u003e\n\u003ctd\u003e≈35%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eStryker margin impact (2024)\u003c\/td\u003e\n\u003ctd\u003e−0.8 pp\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eStryker Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Porter’s Five Forces analysis for Stryker you'll receive immediately after purchase—no surprises, no placeholders. The document displayed is fully formatted and ready for download and use the moment you buy. You're looking at the actual, final file; once you complete your purchase, you’ll get instant access to this same document. No mockups or samples—the preview is the deliverable.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56747459969401,"sku":"stryker-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/stryker-five-forces-analysis.png?v=1772198727","url":"https:\/\/growthsharematrix.com\/products\/stryker-five-forces-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}